Brief report on use of pembrolizumab with or without chemotherapy for advanced lung cancer: A real-world analysis

Authors

• Monika A. Izano, Syapse, San Francisco, CA, USA. Electronic address: Monika.Izano@syapse.com.
• Connor Sweetnam, Syapse, San Francisco, CA, USA.
• Chenan Zhang, Syapse, San Francisco, CA, USA.
• James L. Weese, Advocate Aurora HealthFollow
• Douglas Reding, Ascension, Milwaukee, WI.
• Jonathan Treisman, Ascension, Milwaukee, WI.
• Anand Patel, Ascension, Milwaukee, WI.
• Bindu Potugari, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.
• Andrew Stafford, Syapse, San Francisco, CA, USA.
• Frank M. Wolf, Syapse, San Francisco, CA, USA.
• Mary Tran, Syapse, San Francisco, CA, USA.
• Thomas D. Brown, Syapse, San Francisco, CA, USA.Follow
• Shirish M. Gadgeel, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.

Recommended Citation

Izano MA, Sweetnam C, Zhang C, et al. Brief Report on Use of Pembrolizumab With or Without Chemotherapy for Advanced Lung Cancer: A Real-World Analysis. Clin Lung Cancer. 2023;24(4):362-365. doi:10.1016/j.cllc.2023.01.011

Type

Article

PubMed ID

36863970